ERIC ROHREN to Protein Kinase Inhibitors
This is a "connection" page, showing publications ERIC ROHREN has written about Protein Kinase Inhibitors.
Connection Strength
0.070
-
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. Clin Cancer Res. 2011 Sep 15; 17(18):6052-60.
Score: 0.070
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.